CVRX
CVRx, Inc.
Price Chart
No historical data available
Latest Quote
$3.03
| Previous Close | $3.04 |
| Open | $3.03 |
| Day High | $3.15 |
| Day Low | $3.01 |
| Volume | 270,608 |
Stock Information
| Shares Outstanding | 26.64M |
| Total Debt | $59.39M |
| Cash Equivalents | $64.59M |
| Revenue | $61.19M |
| Net Income | $-51.97M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $78.59M |
| EPS (TTM) | $-1.92 |
| Exchange | NMS |
Recent Price History
About CVRx, Inc.
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
đ° Latest News
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $8,311,000 | $8,334,000 | $6,256,000 | $4,999,000 |
| Cost Of Revenue | $8,311,000 | $8,334,000 | $6,256,000 | $4,999,000 |
| Total Revenue | $56,651,000 | $51,292,000 | $39,295,000 | $22,469,000 |
| Operating Revenue | $56,651,000 | $51,292,000 | $39,295,000 | $22,469,000 |
| Expenses | ||||
| Interest Expense | $5,827,000 | $4,397,000 | $1,799,000 | $165,000 |
| Total Expenses | $107,916,000 | $110,782,000 | $82,398,000 | $64,996,000 |
| Other Income Expense | $3,768,000 | $3,977,000 | $3,850,000 | $1,373,000 |
| Other Non Operating Income Expenses | $3,768,000 | $3,977,000 | $3,850,000 | $1,373,000 |
| Net Non Operating Interest Income Expense | $-5,827,000 | $-4,397,000 | $-1,799,000 | $-165,000 |
| Interest Expense Non Operating | $5,827,000 | $4,397,000 | $1,799,000 | $165,000 |
| Operating Expense | $99,605,000 | $102,448,000 | $76,142,000 | $59,997,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-53,306,000 | $-59,965,000 | $-41,199,000 | $-41,428,000 |
| Net Interest Income | $-5,827,000 | $-4,397,000 | $-1,799,000 | $-165,000 |
| Normalized Income | $-53,306,000 | $-59,965,000 | $-41,199,000 | $-41,428,000 |
| Net Income From Continuing And Discontinued Operation | $-53,306,000 | $-59,965,000 | $-41,199,000 | $-41,428,000 |
| Total Operating Income As Reported | $-51,265,000 | $-59,490,000 | $-43,103,000 | $-42,527,000 |
| Net Income Common Stockholders | $-53,306,000 | $-59,965,000 | $-41,199,000 | $-41,428,000 |
| Net Income | $-53,306,000 | $-59,965,000 | $-41,199,000 | $-41,428,000 |
| Net Income Including Noncontrolling Interests | $-53,306,000 | $-59,965,000 | $-41,199,000 | $-41,428,000 |
| Net Income Continuous Operations | $-53,306,000 | $-59,965,000 | $-41,199,000 | $-41,428,000 |
| Pretax Income | $-53,324,000 | $-59,910,000 | $-41,052,000 | $-41,319,000 |
| Operating Income | $-51,265,000 | $-59,490,000 | $-43,103,000 | $-42,527,000 |
| Gross Profit | $48,340,000 | $42,958,000 | $33,039,000 | $17,470,000 |
| Per Share | ||||
| Diluted EPS | $-2.04 | $-2.65 | $-1.99 | $-2.02 |
| Basic EPS | $-2.04 | $-2.65 | $-1.99 | $-2.02 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-46,741,000 | $-54,894,000 | $-38,731,000 | $-40,742,000 |
| Reconciled Depreciation | $756,000 | $619,000 | $522,000 | $412,000 |
| EBITDA (Bullshit earnings) | $-46,741,000 | $-54,894,000 | $-38,731,000 | $-40,742,000 |
| EBIT | $-47,497,000 | $-55,513,000 | $-39,253,000 | $-41,154,000 |
| Diluted Average Shares | $26,084,709 | $22,596,229 | $20,754,375 | $20,532,838 |
| Basic Average Shares | $26,084,709 | $22,596,229 | $20,754,375 | $20,532,838 |
| Diluted NI Availto Com Stockholders | $-53,306,000 | $-59,965,000 | $-41,199,000 | $-41,428,000 |
| Tax Provision | $-18,000 | $55,000 | $147,000 | $109,000 |
| Research And Development | $11,132,000 | $11,131,000 | $11,633,000 | $9,952,000 |
| Selling General And Administration | $88,473,000 | $91,317,000 | $64,509,000 | $50,045,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $39,324,000 | $71,055,000 | $75,947,000 | $109,180,000 |
| Total Assets | $104,794,000 | $133,414,000 | $115,229,000 | $124,937,000 |
| Total Non Current Assets | $3,147,000 | $3,601,000 | $3,139,000 | $2,059,000 |
| Other Non Current Assets | $26,000 | $27,000 | $27,000 | $27,000 |
| Current Assets | $101,647,000 | $129,813,000 | $112,090,000 | $122,878,000 |
| Other Current Assets | $3,069,000 | $2,505,000 | $2,987,000 | $4,223,000 |
| Inventory | $12,205,000 | $12,107,000 | $10,983,000 | $6,957,000 |
| Receivables | $10,665,000 | $9,268,000 | $7,551,000 | $5,504,000 |
| Accounts Receivable | $10,665,000 | $9,268,000 | $7,551,000 | $5,504,000 |
| Allowance For Doubtful Accounts Receivable | $-871,000 | $-780,000 | $-508,000 | $-679,000 |
| Gross Accounts Receivable | $11,536,000 | $10,048,000 | $8,059,000 | $6,183,000 |
| Cash Cash Equivalents And Short Term Investments | $75,708,000 | $105,933,000 | $90,569,000 | $106,194,000 |
| Cash And Cash Equivalents | $75,708,000 | $105,933,000 | $90,569,000 | $106,194,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $50,504,000 | $50,432,000 | $30,613,000 | $7,086,000 |
| Long Term Debt And Capital Lease Obligation | $50,152,000 | $50,150,000 | $30,382,000 | $6,864,000 |
| Long Term Debt | $49,514,000 | $49,273,000 | $29,222,000 | $6,747,000 |
| Current Debt And Capital Lease Obligation | $352,000 | $282,000 | $231,000 | $222,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $65,470,000 | $62,359,000 | $39,282,000 | $15,757,000 |
| Total Non Current Liabilities Net Minority Interest | $52,153,000 | $51,597,000 | $31,418,000 | $7,669,000 |
| Other Non Current Liabilities | $2,001,000 | $1,447,000 | $1,036,000 | $805,000 |
| Current Liabilities | $13,317,000 | $10,762,000 | $7,864,000 | $8,088,000 |
| Payables And Accrued Expenses | $5,999,000 | $4,806,000 | $3,528,000 | $4,603,000 |
| Interest Payable | $403,000 | $437,000 | $220,000 | - |
| Payables | $3,926,000 | $2,717,000 | $2,009,000 | $1,839,000 |
| Total Tax Payable | $93,000 | $135,000 | $125,000 | $120,000 |
| Accounts Payable | $3,833,000 | $2,582,000 | $1,884,000 | $1,719,000 |
| Equity | ||||
| Common Stock Equity | $39,324,000 | $71,055,000 | $75,947,000 | $109,180,000 |
| Total Equity Gross Minority Interest | $39,324,000 | $71,055,000 | $75,947,000 | $109,180,000 |
| Stockholders Equity | $39,324,000 | $71,055,000 | $75,947,000 | $109,180,000 |
| Gains Losses Not Affecting Retained Earnings | $-203,000 | $-206,000 | $-207,000 | $-207,000 |
| Other Equity Adjustments | $-203,000 | $-206,000 | $-207,000 | $-207,000 |
| Retained Earnings | $-590,652,000 | $-537,346,000 | $-477,381,000 | $-436,182,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $26,311,607 | $25,324,684 | $20,879,199 | $20,633,736 |
| Share Issued | $26,311,607 | $25,324,684 | $20,879,199 | $20,633,736 |
| Tangible Book Value | $39,324,000 | $71,055,000 | $75,947,000 | $109,180,000 |
| Invested Capital | $88,838,000 | $120,328,000 | $105,169,000 | $115,927,000 |
| Working Capital | $88,330,000 | $119,051,000 | $104,226,000 | $114,790,000 |
| Capital Lease Obligations | $990,000 | $1,159,000 | $1,391,000 | $339,000 |
| Total Capitalization | $88,838,000 | $120,328,000 | $105,169,000 | $115,927,000 |
| Additional Paid In Capital | $629,916,000 | $608,354,000 | $553,326,000 | $545,362,000 |
| Capital Stock | $263,000 | $253,000 | $209,000 | $207,000 |
| Common Stock | $263,000 | $253,000 | $209,000 | $207,000 |
| Long Term Capital Lease Obligation | $638,000 | $877,000 | $1,160,000 | $117,000 |
| Current Capital Lease Obligation | $352,000 | $282,000 | $231,000 | $222,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $6,966,000 | $5,674,000 | $4,105,000 | $3,263,000 |
| Current Accrued Expenses | $2,073,000 | $2,089,000 | $1,519,000 | $2,764,000 |
| Net PPE | $3,121,000 | $3,574,000 | $3,112,000 | $2,032,000 |
| Accumulated Depreciation | $-4,148,000 | $-3,407,000 | $-2,788,000 | $-2,280,000 |
| Gross PPE | $7,269,000 | $6,981,000 | $5,900,000 | $4,312,000 |
| Leases | $827,000 | $542,000 | $98,000 | $95,000 |
| Construction In Progress | $325,000 | $720,000 | $554,000 | $231,000 |
| Other Properties | $4,411,000 | $4,213,000 | $4,070,000 | $3,018,000 |
| Machinery Furniture Equipment | $1,706,000 | $1,506,000 | $1,178,000 | $968,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $3,104,000 | $4,897,000 | $5,615,000 | $3,534,000 |
| Work In Process | $473,000 | $353,000 | $654,000 | $1,033,000 |
| Raw Materials | $8,628,000 | $6,857,000 | $4,714,000 | $2,390,000 |
| Treasury Shares Number | - | - | $0 | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-40,750,000 | $-40,505,000 | $-39,612,000 | $-43,362,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-40,170,000 | $-39,144,000 | $-39,021,000 | $-42,677,000 |
| Cash Flow From Continuing Operating Activities | $-40,170,000 | $-39,144,000 | $-39,021,000 | $-42,677,000 |
| Operating Gains Losses | $86,000 | - | $4,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-580,000 | $-1,361,000 | $-591,000 | $-685,000 |
| Investing Cash Flow | $-580,000 | $-1,361,000 | $-591,000 | $-685,000 |
| Cash Flow From Continuing Investing Activities | $-580,000 | $-1,361,000 | $-591,000 | $-685,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $8,974,000 | $32,521,000 | $0 | $0 |
| Financing Cash Flow | $10,520,000 | $55,870,000 | $23,984,000 | $7,493,000 |
| Cash Flow From Continuing Financing Activities | $10,520,000 | $55,870,000 | $23,984,000 | $7,493,000 |
| Net Common Stock Issuance | $8,974,000 | $32,521,000 | $0 | $0 |
| Common Stock Issuance | $8,974,000 | $32,521,000 | $0 | $0 |
| Net Other Financing Charges | - | $-152,000 | $-179,000 | $-778,000 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Issuance Of Debt | $0 | $20,000,000 | $22,500,000 | $7,500,000 |
| Interest Paid Supplemental Data | $5,045,000 | $3,614,000 | $1,396,000 | $59,000 |
| End Cash Position | $75,708,000 | $105,933,000 | $90,569,000 | $106,194,000 |
| Beginning Cash Position | $105,933,000 | $90,569,000 | $106,194,000 | $142,072,000 |
| Effect Of Exchange Rate Changes | $5,000 | $-1,000 | $3,000 | $-9,000 |
| Changes In Cash | $-30,230,000 | $15,365,000 | $-15,628,000 | $-35,869,000 |
| Proceeds From Stock Option Exercised | $1,546,000 | $3,501,000 | $1,663,000 | $771,000 |
| Net Issuance Payments Of Debt | $0 | $20,000,000 | $22,500,000 | $7,500,000 |
| Net Long Term Debt Issuance | $0 | $20,000,000 | $22,500,000 | $7,500,000 |
| Long Term Debt Issuance | $0 | $20,000,000 | $22,500,000 | $7,500,000 |
| Net PPE Purchase And Sale | $-580,000 | $-1,361,000 | $-591,000 | $-685,000 |
| Purchase Of PPE | $-580,000 | $-1,361,000 | $-591,000 | $-685,000 |
| Change In Working Capital | $1,001,000 | $949,000 | $-4,805,000 | $-5,573,000 |
| Change In Payables And Accrued Expense | $3,039,000 | $3,259,000 | $-5,000 | $2,082,000 |
| Change In Accrued Expense | $1,788,000 | $2,561,000 | $-170,000 | $873,000 |
| Change In Payable | $1,251,000 | $698,000 | $165,000 | $1,209,000 |
| Change In Account Payable | $1,251,000 | $698,000 | $165,000 | $1,209,000 |
| Change In Prepaid Assets | $-543,000 | $531,000 | $1,273,000 | $-1,634,000 |
| Change In Inventory | $-98,000 | $-1,124,000 | $-4,026,000 | $-3,077,000 |
| Change In Receivables | $-1,397,000 | $-1,717,000 | $-2,047,000 | $-2,944,000 |
| Changes In Account Receivables | $-1,397,000 | $-1,717,000 | $-2,047,000 | $-2,944,000 |
| Other Non Cash Items | $241,000 | $203,000 | $154,000 | $25,000 |
| Stock Based Compensation | $11,052,000 | $19,050,000 | $6,303,000 | $3,887,000 |
| Depreciation Amortization Depletion | $756,000 | $619,000 | $522,000 | $412,000 |
| Depreciation And Amortization | $756,000 | $619,000 | $522,000 | $412,000 |
| Depreciation | $756,000 | $619,000 | $522,000 | $412,000 |
| Gain Loss On Sale Of PPE | $86,000 | $0 | $4,000 | $0 |
| Net Income From Continuing Operations | $-53,306,000 | $-59,965,000 | $-41,199,000 | $-41,428,000 |
| Income Tax Paid Supplemental Data | - | $0 | $4,000 | $5,000 |
| Repayment Of Debt | - | - | - | $0 |
| Common Stock Payments | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | - |